BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 31231393)

  • 1. Mesenchymal Stromal Cells for Transplant Tolerance.
    Podestà MA; Remuzzi G; Casiraghi F
    Front Immunol; 2019; 10():1287. PubMed ID: 31231393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance.
    Johnstone BH; Messner F; Brandacher G; Woods EJ
    Front Immunol; 2021; 12():622604. PubMed ID: 33732244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stromal cells in renal transplantation: opportunities and challenges.
    Casiraghi F; Perico N; Cortinovis M; Remuzzi G
    Nat Rev Nephrol; 2016 Apr; 12(4):241-53. PubMed ID: 26853275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stromal cells for tolerance induction in organ transplantation.
    Casiraghi F; Perico N; Remuzzi G
    Hum Immunol; 2018 May; 79(5):304-313. PubMed ID: 29288697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stromal cells to promote solid organ transplantation tolerance.
    Casiraghi F; Perico N; Remuzzi G
    Curr Opin Organ Transplant; 2013 Feb; 18(1):51-8. PubMed ID: 23254705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stromal Cell Therapy in Solid Organ Transplantation.
    Podestà MA; Remuzzi G; Casiraghi F
    Front Immunol; 2020; 11():618243. PubMed ID: 33643298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stromal cells in transplantation rejection and tolerance.
    English K; Wood KJ
    Cold Spring Harb Perspect Med; 2013 May; 3(5):a015560. PubMed ID: 23637312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stromal cells to control donor-specific memory T cells in solid organ transplantation.
    Cortinovis M; Casiraghi F; Remuzzi G; Perico N
    Curr Opin Organ Transplant; 2015 Feb; 20(1):79-85. PubMed ID: 25563995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells and their immunosuppressive role in transplantation tolerance.
    Contreras-Kallens P; Terraza C; Oyarce K; Gajardo T; Campos-Mora M; Barroilhet MT; Álvarez C; Fuentes R; Figueroa F; Khoury M; Pino-Lagos K
    Ann N Y Acad Sci; 2018 Apr; 1417(1):35-56. PubMed ID: 28700815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study.
    Erpicum P; Weekers L; Detry O; Bonvoisin C; Delbouille MH; Grégoire C; Baudoux E; Briquet A; Lechanteur C; Maggipinto G; Somja J; Pottel H; Baron F; Jouret F; Beguin Y
    Kidney Int; 2019 Mar; 95(3):693-707. PubMed ID: 30528263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin.
    Wang H; Qi F; Dai X; Tian W; Liu T; Han H; Zhang B; Li H; Zhang Z; Du C
    Transpl Immunol; 2014 Aug; 31(2):65-74. PubMed ID: 24978830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multipotent mesenchymal stromal cells in kidney transplant recipients: The next big thing?
    Sergeant E; Buysse M; Devos T; Sprangers B
    Blood Rev; 2021 Jan; 45():100718. PubMed ID: 32507576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal Stromal Cells in Solid Organ Transplantation.
    Vandermeulen M; Erpicum P; Weekers L; Briquet A; Lechanteur C; Detry O; Beguin Y; Jouret F
    Transplantation; 2020 May; 104(5):923-936. PubMed ID: 31929427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. iPSC-derived MSC therapy induces immune tolerance and supports long-term graft survival in mouse orthotopic tracheal transplants.
    Khan MA; Alanazi F; Ahmed HA; Shamma T; Kelly K; Hammad MA; Alawad AO; Assiri AM; Broering DC
    Stem Cell Res Ther; 2019 Sep; 10(1):290. PubMed ID: 31547869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Tolerance Induction Using Cell-Based Strategies in Liver Transplantation: Clinical Perspectives.
    Wang P; Jiang Z; Wang C; Liu X; Li H; Xu D; Zhong L
    Front Immunol; 2020; 11():1723. PubMed ID: 33013824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation.
    Lohan P; Murphy N; Treacy O; Lynch K; Morcos M; Chen B; Ryan AE; Griffin MD; Ritter T
    Front Immunol; 2018; 9():2666. PubMed ID: 30515159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate.
    Popp FC; Eggenhofer E; Renner P; Slowik P; Lang SA; Kaspar H; Geissler EK; Piso P; Schlitt HJ; Dahlke MH
    Transpl Immunol; 2008 Nov; 20(1-2):55-60. PubMed ID: 18762258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study.
    Detry O; Vandermeulen M; Delbouille MH; Somja J; Bletard N; Briquet A; Lechanteur C; Giet O; Baudoux E; Hannon M; Baron F; Beguin Y
    J Hepatol; 2017 Jul; 67(1):47-55. PubMed ID: 28284916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stromal cells to promote kidney transplantation tolerance.
    Casiraghi F; Remuzzi G; Perico N
    Curr Opin Organ Transplant; 2014 Feb; 19(1):47-53. PubMed ID: 24257324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The innate immune system in allograft rejection and tolerance.
    LaRosa DF; Rahman AH; Turka LA
    J Immunol; 2007 Jun; 178(12):7503-9. PubMed ID: 17548582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.